Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/31/2003WO2003035004A9 Immunotherapy for reversing immune suppression
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002088347A3 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002057469A3 Modulating developmental transitions in plants
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038766A3 Human tumor necrosis factor receptor
12/31/2003WO2002036789A3 Methods of modifying eukaryotic cells
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464905A Device and method for cultivation
12/31/2003CN1464060A Bridsfoot trefoil pattern schema and anthotaxis structure regulating gene encoding protein and use thereof
12/31/2003CN1464056A Process for the manufacture of cultivatable disease resistant plant somatic cell hybrid
12/31/2003CN1463593A Process for preparing type C hepatitis virus natural infestation mice model and use thereof
12/31/2003CN1132939C Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CA2740137A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
12/31/2003CA2495395A1 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
12/31/2003CA2490771A1 Thioesterase-related nucleic acid sequences and methods
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490245A1 Tangential flow filtration devices and methods for leukocyte enrichment
12/31/2003CA2490195A1 A non-blended soybean oil with high oleic acid content
12/31/2003CA2490004A1 Plastid division and related genes and proteins, and methods of use
12/31/2003CA2489905A1 Osteopontin, oligodendrocytes and myelination
12/31/2003CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease
12/31/2003CA2480892A1 Novel promoter
12/31/2003CA2478508A1 Stable adenoviral vectors and methods for propagation thereof
12/30/2003US6670527 Gibberellin 2-oxidase
12/30/2003US6670525 Transgenic plants and cells with altered degree of amylopectin branching
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670451 Netrins
12/30/2003US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression.
12/30/2003US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670199 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
12/30/2003US6670189 Fumonisin detoxification compositions and methods
12/30/2003US6670188 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670185 Compositions and methods for non-targeted activation of endogenous genes
12/30/2003US6670184 Method for producing a lipid emulsion for use in insect cell culture
12/30/2003US6670180 Nutrient broth for use in the propagation of hepatocytes
12/30/2003US6670179 Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670171 Apparatus for use in the propagation and analysis of cells
12/30/2003US6670167 Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6670146 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669936 Gene therapy
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003US20030237109 Flower-bud formation suppressor gene and early flowering plant
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236392 Genetic engineering; polypeptide library
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236320 Polyhydroxyalkanoate compositions having controlled degradation rates
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030236206 Diagnosis of disease; screening antibodies
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030235913 Hybrid nucleic acid; screening antibodies
12/25/2003US20030235912 Screening antibodies; cardiovascular disorders; gastrointestinal disorders
12/25/2003US20030235911 Hybrid nucleic acid
12/25/2003US20030235909 Embryo cells from placenta
12/25/2003US20030235908 Adjusting lymphocyte concentration; closed container; discharging filter
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof
12/25/2003US20030235898 Nematode GS-like sequences
12/25/2003US20030235889 Materials and methods involving conditional retention domains
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235886 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
12/25/2003US20030235880 Genetic engineered nucleic acid
12/25/2003US20030235870 Sperm quality assay
12/25/2003US20030235842 Map
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235831 Nucleic acids, proteins, and antibodies
12/25/2003US20030235829 Nucleic acids, proteins, and antibodies
12/25/2003US20030235826 Gene and protein specific for excitable tissues
12/25/2003US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents
12/25/2003US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235582 Anti-IGF-I receptor antibody
12/25/2003US20030235563 Placental derived stem cells and uses thereof
12/25/2003US20030235562 Introducing a nucleic acid sequence encoding a lifespan extending or immortalizing protein product, under conditions such that it is expressed and a protein product is produced and engineering into a vascular graft
12/25/2003US20030235561 Vascularized organized tissues and uses thereof
12/25/2003US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence
12/25/2003US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
12/25/2003US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer
12/24/2003WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms
12/24/2003WO2003107006A1 Oxaliplatin anti-resistance agent
12/24/2003WO2003106970A2 P27 prevents cellular migration
12/24/2003WO2003106700A1 Method of cell culture
12/24/2003WO2003106695A2 Methods and compositions for in vivo clearance of pathogens
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106688A1 Glucosyltransferases which clucosylate salicylic acid
1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 1827